AP2A2 Protein

AP2A2 Protein

<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">AP2A2 Protein</th></tr> [@treusch2011]
<tr><td><strong>Protein Name</strong></td><td>AP-2 Complex Subunit Alpha 2</td></tr> [@owen2000]
<tr><td><strong>Gene</strong></td><td><a href="/genes/ap2a2">AP2A2</a></td></tr> [@mcmahon2011]
<tr><td><strong>UniProt ID</strong></td><td><a href="https://www.uniprot.org/uniprot/O95773">O95773</a></td></tr> [@small2006]
<tr><td><strong>Molecular Weight</strong></td><td>~104 kDa</td></tr> [@benussi2022]
<tr><td><strong>Subcellular Localization</strong></td><td>Clathrin-coated vesicles, plasma membrane</td></tr> [@fallini2012]
<tr><td><strong>Protein Family</strong></td><td>Adaptor protein complex family</td></tr> [@moshiri2020]
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
</div>

Overview

AP2A2 Protein

<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">AP2A2 Protein</th></tr> [@treusch2011]
<tr><td><strong>Protein Name</strong></td><td>AP-2 Complex Subunit Alpha 2</td></tr> [@owen2000]
<tr><td><strong>Gene</strong></td><td><a href="/genes/ap2a2">AP2A2</a></td></tr> [@mcmahon2011]
<tr><td><strong>UniProt ID</strong></td><td><a href="https://www.uniprot.org/uniprot/O95773">O95773</a></td></tr> [@small2006]
<tr><td><strong>Molecular Weight</strong></td><td>~104 kDa</td></tr> [@benussi2022]
<tr><td><strong>Subcellular Localization</strong></td><td>Clathrin-coated vesicles, plasma membrane</td></tr> [@fallini2012]
<tr><td><strong>Protein Family</strong></td><td>Adaptor protein complex family</td></tr> [@moshiri2020]
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
</div>

Overview

AP2A2 (AP-2 Complex Subunit Alpha 2) is a critical component of the clathrin adaptor protein complex 2 (AP-2), one of the major coat proteins involved in clathrin-mediated endocytosis (CME) [1]. The AP-2 complex is a heterotetramer composed of four subunits: two large chains (α and β2), one medium chain (μ2), and one small chain (σ2). AP2A2, as the α-adaptin subunit, plays essential roles in cargo recognition, clathrin coat assembly, and synaptic vesicle recycling at presynaptic terminals [2]. The protein is particularly important in the nervous system, where it facilitates the rapid recycling of synaptic vesicles and the internalization of various receptors and transporters. Dysregulation of AP2A2 has been implicated in neurodegenerative diseases, particularly Alzheimer's disease, where altered endocytic trafficking contributes to amyloid-β production and pathological accumulation [3].

Structure

The AP-2 complex adopts a characteristic architecture with distinct functional domains:

AP2A2 Subunit Structure

• N-terminal Trunk Region: Binds to clathrin and other coat components
• Head Domain: Contains the cargo-binding pocket
• Linker Region: Connects head to the appendage domain
• C-terminal Appendage: Functions as a protein-protein interaction platform
• Molecular Weight: ~104 kDa

AP-2 Complex Architecture

• α-Adaptin (AP2A2): ~100 kDa
• β2-Adaptin: ~100 kDa
• μ2 Subunit: ~50 kDa
• σ2 Subunit: ~20 kDa

Normal Function

Clathrin-Mediated Endocytosis

AP2A2 is central to clathrin-mediated endocytosis [5]:

Cargo Selection:

• Recognizes transmembrane cargo proteins
• Binds to cytoplasmic tails of receptors
• Selects specific membrane proteins for internalization

• Initiates clathrin coat formation
• Recruits clathrin triskelions
• Facilitates membrane deformation

• Essential for presynaptic vesicle reformation
• Mediates rapid endocytosis of synaptic vesicle membranes
• Controls quantal neurotransmitter release

Membrane Trafficking

AP2A2 participates in multiple trafficking pathways:

Receptor Internalization:

• Growth factor receptors (EGFR, PDGFR)
• G-protein coupled receptors
• Transferrin receptor
• Ion channels

• Cholesterol metabolism (LDL receptor)
• Iron transport (transferrin receptor)
• Glucose transport (GLUT4)

• Neurotransmitter receptor recycling
• Synaptic vesicle protein retrieval
• Postsynaptic receptor internalization

Cellular Homeostasis

AP2A2 maintains cellular homeostasis through:

• Plasma Membrane Composition: Regulates surface protein levels
• Signal Transduction: Controls receptor signaling duration
• Nutrient Sensing: Internalizes metabolic receptors

Role in Disease

Alzheimer's Disease

AP2A2 dysfunction significantly contributes to AD pathogenesis [6]:

Amyloid-β Production:

• Altered endocytic trafficking increases [amyloid precursor protein](/entities/app-protein) (APP) internalization
• Enhanced [γ-secretase](/entities/gamma-secretase) access to APP
• Elevated [Aβ](/proteins/amyloid-beta) generation and secretion

• Endocytic dysfunction precedes plaque formation
• Accumulation of early endosomes in [neurons](/entities/neurons)
• Enhanced Aβ uptake and aggregation

• Targeting AP2A2-dependent endocytosis
• Modulating APP trafficking
• Reducing Aβ production through endocytic pathway regulation

Parkinson's Disease

AP2A2 plays roles in PD pathogenesis [7]:

[α-Synuclein](/proteins/alpha-synuclein) Internalization:

• Mediates cellular uptake of α-synuclein
• Contributes to prion-like propagation
• Facilitates interneuronal transmission

• Controls DAT internalization and recycling
• Alters dopaminergic signaling
• Affects PD drug response

Amyotrophic Lateral Sclerosis (ALS)

AP2A2 involvement in ALS [8]:

[TDP-43](/mechanisms/tdp-43-proteinopathy) Trafficking:

• Dysregulated endocytosis affects TDP-43 localization
• Alters RNA-protein complex transport
• Contributes to cytoplasmic aggregation

• Impaired synaptic vesicle recycling
• Altered neurotransmitter release
• Motor neuron vulnerability

Cancer

AP2A2 is dysregulated in various cancers [9]:

Oncogenic Signaling:

• Altered growth factor receptor internalization
• Enhanced proliferation signals
• Reduced [apoptosis](/entities/apoptosis)

• Increased invasive capacity
• Altered cell adhesion
• Enhanced motility

Interacting Partners

| Protein | Interaction Type | Functional Significance |
|---------|------------------|------------------------|
| Clathrin | Structural component | Coat formation |
| β2-Adaptin | Complex subunit | Heterotetramer formation |
| μ2 (PICALM) | Complex subunit | Cargo recognition |
| Amphiphysin | BAR domain protein | Membrane curvature |
| Dynamin | GTPase | Vesicle scission |
| Synaptojanin | Phosphatase | Uncoating |
| Endophilin | BAR domain protein | Membrane remodeling |

Therapeutic Approaches

Targeting AP2A2 and associated pathways:

Genetic Variation

Polymorphisms in AP2A2 affect disease risk:

• SNPs: Associated with AD risk
• Expression Variants: Altered protein levels in disease
• Functional Consequences: Affect cargo recognition

See Also

• [AP2A2 Gene](/genes/ap2a2)
• [Endocytosis in Neurodegeneration](/mechanisms/endocytosis)
• [Clathrin-Mediated Synaptic Vesicle Recycling](/mechanisms/synaptic-vesicle-recycling)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)

External Links

• [UniProt O95773](https://www.uniprot.org/uniprot/O95773)
• [GeneCards AP2A2](https://www.genecards.org/cgi-bin/carddisp.pl?gene=AP2A2)
• [NCBI Gene AP2A2](https://www.ncbi.nlm.nih.gov/gene/161)
• [IUPHAR Adaptor Proteins](https://www.guidetopharmacology.org/record/GPCR/1928)

References